The letter of Finsterer and Stollberger was shown to the authors who replied.
Markiewicz-Loskot
Grazyna
G
Moric-Janiszewska
Ewa
E
Loskot
Maria
M
Szydłowski
Lesław
L
Weglarz
Ludmiła
L
Hollek
Andrzej
A
D000217:Acyltransferases; D009202:Cardiomyopathies / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D002675:Child, Preschool; D002877:Chromosomes, Human / Q000235:genetics; D049029:Dystrophin-Associated Proteins / Q000235:genetics; D005260:Female; D005500:Follow-Up Studies; D030342:Genetic Diseases, Inborn / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology; D006330:Heart Defects, Congenital / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology; D006333:Heart Failure / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology; D006801:Humans; D007223:Infant; D007438:Introns / Q000235:genetics; D034904:Lamin Type A / Q000235:genetics; D008297:Male; D020125:Mutation, Missense; D011506:Proteins / Q000235:genetics; D022821:RNA Splice Sites / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics; D022061:Tacrolimus Binding Protein 1A / Q000235:genetics; D014157:Transcription Factors / Q000235:genetics
D049029:Dystrophin-Associated Proteins; C494847:LMNA protein, human; D034904:Lamin Type A; D011506:Proteins; D022821:RNA Splice Sites; D012333:RNA, Messenger; D014157:Transcription Factors; C098885:dystrobrevin; D000217:Acyltransferases; C108675:TAFAZZIN protein, human; D022061:Tacrolimus Binding Protein 1A